Munchen, Germany
SurgicEye GmbH, founded in 2008 and headquartered in Germany, is pioneering advancements in intra-operative imaging and instrument navigation. With a focus on expanding the use of nuclear medicine images, the company offers the declipseSPECT Suite to enhance surgical precision and efficiency.
The suite's capabilities include application-specific imaging, hybrid imaging through ultrasound SPECT fusion, and various intraoperative imaging solutions. Key applications target improved diagnostics and techniques in thyroid cancer, parathyroid detection, sentinel lymph node mapping and biopsy, among other radio-guided surgical procedures.
The last reported investment for SurgicEye GmbH was a grant of €150.00K received on 01 July 2012. This highlights a period of financial dormancy that might appeal to investors looking to revitalize and capitalize on emerging medical imaging technologies.
-logo.jpg "Society of Nuclear Medicine and Molecular Imaging (SNMMI)"){kind=logo}
